Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Racadot

Showing results (371-380 of 381) with videos related to

Pageof 39
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2025
Consensus for a postoperative atlas of sinonasal substructures from a modified Delphi study to guide radiotherapy in sinonasal malignanciesFlorent Carsuzaa, Valentin Favier, Lise Seguin, et al.
The Lancet. Healthy Longevity|February 19, 2026
Hypofractionated split-course versus standard radiotherapy in frail older patients with head and neck squamous-cell carcinoma (ELAN-RT trial): a non-inferiority, multicentre, open-label, randomised controlled trialCécile Ortholan, Anne Aupérin, Yungan Tao, et al.
International Journal of Radiation Oncology, Biology, Physics|August 2, 2025
Late Toxicities and Quality of Life After a Radiation Boost for Breast Ductal Carcinoma In Situ: Boost or No Boost in DCIS Randomized TrialCeline Bourgier, Caroline Mollevi, Didier Cowen, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 27, 2021
Histosurgical mapping of endoscopic endonasal surgery of sinonasal tumours to improve radiotherapy guidanceT Leleu, V Bastit, M Doré, et al.
Bulletin Du Cancer|October 16, 2013
[Advances in head and neck cancers on behalf of the French Intergroup ORL and GORTEC]J Thariat, F Jegoux, Y Pointreau, et al.
BMC Cancer|December 4, 2025
Intraoperative radiotherapy in elderly patients with breast cancer: long-term follow-up results of the prospective phase II trial TARGIT-EElena Sperk, Claire Lemanski, Christian Neumaier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 16, 2008
[Ductal carcinoma in situ: role of the boost]D Azria, H Auvray, I Barillot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 30, 2021
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC GroupBenjamin Lacas, Alexandra Carmel, Cécile Landais, et al.
Lancet (London, England)|December 25, 2025
Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trialJean Bourhis, Anne Aupérin, Christian Borel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2021
Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensusFlorent Carsuzaa, Michel Lapeyre, Vincent Gregoire, et al.
Pageof 39

Showing results (371-380 of 381) with videos related to

Sort By:
Pageof 39
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2025
Consensus for a postoperative atlas of sinonasal substructures from a modified Delphi study to guide radiotherapy in sinonasal malignanciesFlorent Carsuzaa, Valentin Favier, Lise Seguin, et al.
The Lancet. Healthy Longevity|February 19, 2026
Hypofractionated split-course versus standard radiotherapy in frail older patients with head and neck squamous-cell carcinoma (ELAN-RT trial): a non-inferiority, multicentre, open-label, randomised controlled trialCécile Ortholan, Anne Aupérin, Yungan Tao, et al.
International Journal of Radiation Oncology, Biology, Physics|August 2, 2025
Late Toxicities and Quality of Life After a Radiation Boost for Breast Ductal Carcinoma In Situ: Boost or No Boost in DCIS Randomized TrialCeline Bourgier, Caroline Mollevi, Didier Cowen, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 27, 2021
Histosurgical mapping of endoscopic endonasal surgery of sinonasal tumours to improve radiotherapy guidanceT Leleu, V Bastit, M Doré, et al.
Bulletin Du Cancer|October 16, 2013
[Advances in head and neck cancers on behalf of the French Intergroup ORL and GORTEC]J Thariat, F Jegoux, Y Pointreau, et al.
BMC Cancer|December 4, 2025
Intraoperative radiotherapy in elderly patients with breast cancer: long-term follow-up results of the prospective phase II trial TARGIT-EElena Sperk, Claire Lemanski, Christian Neumaier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 16, 2008
[Ductal carcinoma in situ: role of the boost]D Azria, H Auvray, I Barillot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 30, 2021
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC GroupBenjamin Lacas, Alexandra Carmel, Cécile Landais, et al.
Lancet (London, England)|December 25, 2025
Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trialJean Bourhis, Anne Aupérin, Christian Borel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2021
Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensusFlorent Carsuzaa, Michel Lapeyre, Vincent Gregoire, et al.
Pageof 39